Check out your Company Bowl for anonymous work chats.
Know why and how the big pharmaceuticals are targeting the BET for cancer treatment. While there are numerous studies on developing drugs or measures, targeting the bromodomain and extra-terminal (BET), proteins containing this domain have become epigenetic target for pharmaceutical companies. Here’s a short summary on how these companies are faring upon their clinical studies targeting BET inhibitors to cure cancer. http://glassdoor.com/slink.htm?key=vQ41t
Did you know #Lucentis is the first FDA approved medicine to treat all forms of Diabetic Retinopathy. Roche, Bayer, Novartis It took almost 12 years for the medicine to get approved. KnDid you know #Lucentis is the first FDA approved medicine to treat all forms of Diabetic Retinopathy. Roche, Bayer, Novartis It took almost 12 years for the medicine to get approved. Know the journey of Lucentis here : http://glassdoor.com/slink.htm?key=vQ41F ow the journey of Lucentis here : http://glassdoor.com/slink.htm?key=vQ41E
Nintedanib (Ofev) is a drug developed by Boehringer Ingelheim and approved by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis (IPF), a debilitating and fatal lung disease. To reduce the drug development time and cost significantly, visit http://glassdoor.com/slink.htm?key=vQ419 now! http://glassdoor.com/slink.htm?key=vQ41B
This is our team behind our awesome products. Meet us at #BioIT17 booth #355. Visit http://glassdoor.com/slink.htm?key=vQ41d for more information.
Are you are at Bio-IT World conference and expo- 2017? Visit us at booth #355 for 3 reasons. For more information visit http://glassdoor.com/slink.htm?key=vQ41v http://glassdoor.com/slink.htm?key=vQ41P
We, at Innoplexus, are driven by a single mission of reducing the drug development time significantly using Artificial Intelligence. For next 3 days, we are demonstrating our products and core competencies to the world at our booth #355 at Bio-IT World conference and expo. Meet us and Help Science Win! For more information visit http://glassdoor.com/slink.htm?key=vQ415
Our CEO, Dr Gunjan Bhardwaj is one of the key speakers at Bio-IT World. He will be talking about “Artificial Intelligence powered data and insights” within the conference track no 8 “Clinical research and translational informatics: New technology supporting translational research”. Also visit us at Booth #355 to know how are simplifying Life Science Research. For more information visit http://glassdoor.com/slink.htm?key=vQ41n
We are excited to be a Gold Sponsor at BioIT World conference and expo, 2017. Visit us at Booth #355 to know how are simplifying Life Science Research. For more information visit http://glassdoor.com/slink.htm?key=vQ41X
Innoplexus has been featured in FAZ ( Frankfurter Allgemeine Zeitung ) We are working tirelessly to simplify life sciences research by making it faster, more comprehensive and more cost-effective using artificial intelligence, machine learning, big data analytics etc. For more information visit http://glassdoor.com/slink.htm?key=vQ41C
Did you know that the #WorldAIDSVaccineDay is observed on May 18 every year? The first time it took place on May 18, 1998. The tradition continues today as a good way to remind people about the HIV/AIDS preventive measures. To learn more, visit http://glassdoor.com/slink.htm?key=vQ41A now.
